Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer

Lung Cancer

Volumn 48, Issue 1, 2005, Pages 47-57

  Richardson, C M ^a   Richardson, D ^b   Swinson, D E B ^b   Swain, W A ^b   Cox, G ^c   O'Byrne, K J ^d  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c KING S MILL HOSPITAL   (United Kingdom)

^d ST JAMES S HOSPITAL   (Ireland)

Author keywords

Cyclooxygenase (COX) 2; Epidermal growth factor (EGF); Epidermal growth factor receptor (EGFR); Immunohistochemistry; Non small cell lung cancer (NSCLC); Prognosis

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 15044361542     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.09.007     Document Type: Article

References (49)

1. H. Wolff, K. Saukkonen, S. Anttila, A. Karjalainen, H. Vainio, and A. Ristimaki Expression of cyclooxygenase-2 in human lung carcinoma Cancer Res 58 1998 4997 5001
2. H.Y. Fang, T.S. Lin, J.P. Lin, Y.C. Wu, K.C. Chow, and L.S. Wang Cyclooxygenase-2 in human non-small cell lung cancer Eur J Surg Oncol 29 2003 171 177
3. F.R. Khuri, H. Wu, J.J. Lee, B.L. Kemp, R. Lotan, and S.M. Lippman Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer Clin Cancer Res 7 2001 861 867
4. M.J. Thun, M.M. Namboodiri, and C.W. Heath Jr. Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325 1991 1593 1596
5. K.M. Sheehan, K. Sheahan, D.P. O'Donoghue, F. MacSweeney, R.M. Conroy, and D.J. Fitzgerald The relationship between cyclooxygenase-2 expression and colorectal cancer JAMA 282 1999 1254 1257
6. R. Masunaga, H. Kohno, D.K. Dhar, S. Ohno, M. Shibakita, and S. Kinugasa Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients Clin Cancer Res 6 2000 4064 4068
7. S. Tomozawa, N.H. Tsuno, E. Sunami, K. Hatano, J. Kitayama, and T. Osada Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer Br J Cancer 83 2000 324 328
8. H. Shi, J.M. Xu, N.Z. Hu, H.J. Xie, C.J. Buskens, and B.P. Van Rees Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma World J Gastroenterol 9 2003 1421 1426
9. C.J. Buskens, B.P. Van Rees, A. Sivula, J.B. Reitsma, C. Haglund, and P.J. Bosma Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus Gastroenterology 122 2002 1800 1807
10. Y.E. Joo, W.T. Oh, J.S. Rew, C.S. Park, S.K. Choi, and S.J. Kim Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis Digestion 66 2002 222 229
11. H. Achiwa, Y. Yatabe, T. Hida, T. Kuroishi, K. Kozaki, and S. Nakamura Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas Clin Cancer Res 5 1999 1001 1005
12. A.J. Marrogi, W.D. Travis, J.A. Welsh, M.A. Khan, H. Rahim, and H. Tazelaar Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma Clin Cancer Res 6 2000 4739 4744
13. Y. Hosomi, T. Yokose, Y. Hirose, R. Nakajima, K. Nagai, and Y. Nishiwaki Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung Lung Cancer 30 2000 73 81
14. S. Kulkarni, J.S. Rader, F. Zhang, H. Liapis, A.T. Koki, and J.L. Masferrer Cyclooxygenase-2 is overexpressed in human cervical cancer Clin Cancer Res 7 2001 429 434
15. 2 production in human gingival fibroblasts stimulated with interleukin-1beta and epidermal growth factor Biochem Biophys Res Commun 257 1999 528 532
16. M.A. Molina, M. Sitja-Arnau, M.G. Lemoine, M.L. Frazier, and F.A. Sinicrope Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs Cancer Res 59 1999 4356 4362
17. C.M. Richardson, R.A. Sharma, G. Cox, and K.J. O'Byrne Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy Lung Cancer 39 2003 1 13
18. H. Matsuura, M. Sakaue, K. Subbaramaiah, H. Kamitani, T.E. Eling, and A.J. Dannenberg Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases J Biol Chem 274 1999 29138 29148
19. R.J. Coffey, C.J. Hawkey, L. Damstrup, R. Graves-Deal, V.C. Daniel, and P.J. Dempsey Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells Proc Natl Acad Sci USA 94 1997 657 662
20. D. Saha, P.K. Datta, H. Sheng, J.D. Morrow, M. Wada, and H.L. Moses Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells Neoplasia 1 1999 508 517
21. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy Nat Med 8 2002 289 293
22. G. Tortora, R. Caputo, V. Damiano, D. Melisi, R. Bianco, and G. Fontanini Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect Clin Cancer Res 9 2003 1566 1572
23. F. Hendler, and B. Ozanne Human squamous cell carcinomas express increased epidermal growth factor receptors J Clin Invest 74 1984 651 674
24. D. Veale, N. Kerr, G.J. Gibson, P.J. Kelly, and A.L. Harris The relationship of quantitative epidermal growth factor receptor receptor expression in non-small cell lung cancer to long term survival Br J Cancer 68 1993 162 165
25. A.P. Meert, B. Martin, P. Delmotte, T. Berghmans, J.J. Lafitte, and C. Mascaux The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis Eur Respir J 20 2002 975 981
26. Y. Ohsaki, S. Tanno, Y. Fujita, E. Toyoshima, S. Fujiuchi, and Y. Nishigaki Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression Oncol Rep 7 2000 603 607
27. U. Pastorino, S. Andreola, E. Tagliabue, F. Pezzella, M. Incarbone, and G. Sozzi Immunocytochemical markers in stage I lung cancer: relevance to prognosis J Clin Oncol 15 1997 2858 2865
28. G. Ferrandina, F.O. Ranelletti, L. Lauriola, F. Fanfani, F. Legge, and M. Mottolese Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer Gynecol Oncol 85 2002 305 310
29. F.O. Ranelletti, G. Almadori, B. Rocca, G. Ferrandina, G. Ciabattoni, and A. Habib Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma Int J Cancer 95 2001 343 349
30. G.E. Kim, Y.B. Kim, N.H. Cho, H.C. Chung, H.R. Pyo, and J.D. Lee Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival Clin Cancer Res 10 2004 1366 1374
31. T. Niki, T. Kohno, S. Iba, Y. Moriya, Y. Takahashi, and M. Saito Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas Am J Pathol 160 2002 1129 1141
32. T. Hida, Y. Yatabe, H. Achiwa, H. Muramatsu, K. Kozaki, and S. Nakamura Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas Cancer Res 58 1998 3761 3764
33. H.S. Kim, H.R. Youm, J.S. Lee, K.W. Min, J.H. Chung, and C.S. Park Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer Lung Cancer 42 2003 163 170
34. J. Brabender, J. Park, R. Metzger, P.M. Schneider, R.V. Lord, and A.H. Holscher Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer Ann Surg 235 2002 440 443
35. N.H. Yamaguchi, A.J. Lichtenfels, L.M. Demarchi, A.P. da Silva, A.L. Garippo, and V.F. Alves COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung Am J Clin Pathol 121 2004 78 86
36. R.S. Herbst, and P.M. Kim ESHarari IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer Expert Opin Biol Ther 1 2001 719 732
37. A.J. Colquhoun, and J.K. Mellon Epidermal growth factor receptor and bladder cancer Postgrad Med J 78 2002 584 589
38. Y.B. Kim, G.E. Kim, N.H. Cho, H.R. Pyo, S.J. Shim, and S.K. Chang Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy Cancer 95 2002 531 539
39. G. Selvaggi, S. Novello, V. Torri, E. Leonardo, P. De Giuli, and P. Borasio Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer Ann Oncol 15 2004 28 32
40. D.H. Harpole Jr., W.G. Richards, J.E. Herndon, and D.J. Sugarbaker Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer Ann Thorac Surg 61 1996 1470 1476
41. P. Pfeiffer, P.P. Clausen, K. Andersen, and C. Rose Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections Br. J. Cancer 74 1996 86 91
42. V. Rusch, J. Baselga, C. Cordon-Cardo, J. Orazem, M. Zaman, and S. Hoda Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung Cancer Res 53 1993 2379 2385
43. G. Cox, J.L. Jones, and K.J. O'Byrne Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer Clin Cancer Res 6 2000 2349 2355
44. G. Fontanini, S. Vignati, D. Bigini, A. Mussi, H. Lucchi, and C.A. Angeletti Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype Eur J Cancer 31A 1995 178 183
45. D. Veale, T. Ashcroft, C. Marsh, G.J. Gibson, and A.L. Harris Epidermal growth factor receptors in non-small cell lung cancer Br J Cancer 55 1987 513 516
46. S.Y. Shvartsman, M.P. Hagan, A. Yacoub, P. Dent, H.S. Wiley, and D.A. Lauffenburger Autocrine loops with positive feedback enable context-dependent cell signalling Am J Physiol Cell Physiol 282 2002 C545 C559
47. Y. Umekita, Y. Ohi, Y. Sagara, and H. Yoshida Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients Int J Cancer 89 2000 484 487
48. A. Onn, A.M. Correa, M. Gilcrease, T. Isobe, E. Massarelli, and C.D. Bucana Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer Clin Cancer Res 10 2004 136 143
49. W.J. Rachwal, P.F. Bongiorno, M.B. Orringer, R.I. Whyte, S.P. Ethier, and D.G. Beer Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas Br J Cancer 72 1995 56 64